Copertina

Thrombocytopenia and Bleeding in Patients With Oncologic Emergencies Following Cancer Therapy

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Le Tian, Jia‐Xin Huang, Xi Zhang, Ning Li, Zhi‐Min Bian, Na Li, Shao‐Ming Wang, Xin‐Qi Liu, Zhi‐Yong Li, Qing‐Long Jiang, Chao Wang, Cong Zhao, Wei Wei, Ming‐Hua Cong
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Cancer Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Application of Metagenomic Next‐Generation Sequencing in the Diagnosis of Pneumonia in Patients With Cancer
di: Rong Qin, et al.
Pubblicazione: (2026)

The Clinical Benefits of Nutritional Supplementation Across the Chemotherapy Journey in Cancer Patients: A Multicenter Prospective Cohort Study
di: Jia‐Xin Huang, et al.
Pubblicazione: (2026)

Oncological Outcomes Following Different TACE ‐Based Conversion Therapies for Intermediate‐Advanced Hepatocellular Carcinoma
di: Hongwei Xu, et al.
Pubblicazione: (2026)

Disparities in management guidelines for gastrointestinal stromal tumors: A comparison of recommendations from the Chinese Society of Clinical Oncology, National Comprehensive Cancer Network, and European Society for Medical Oncology
di: Zhidong Gao, et al.
Pubblicazione: (2025)

A liquid biopsy assay for the noninvasive detection of lymph node metastases in T1 lung adenocarcinoma
di: Xin Li, et al.
Pubblicazione: (2024)

Prognostic Implications of Thrombocytopenia in Chinese Patients With Newly Diagnosed Multiple Myeloma
di: Xiaojing Li, et al.
Pubblicazione: (2025)

A Systematic Review of Immune Cell Roles in Breast Cancer Immunotherapy
di: Rui Li, et al.
Pubblicazione: (2025)

Research Progress on Chemokine Signaling Pathways in Primary Immune Thrombocytopenia
di: Dan Li, et al.
Pubblicazione: (2025)

Integrating Nature Into Oncology: Enhancing Hematological Malignancies Therapies With Natural Medicine
di: Yaoyao Tian, et al.
Pubblicazione: (2025)

A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory Immune Thrombocytopenia
di: Bingjie Ding, et al.
Pubblicazione: (2025)

Immunotherapy combined with antiangiogenic therapy as third‐ or further‐line therapy for stage IV non‐small cell lung cancer patients with ECOG performance status 2: A retrospective study
di: Shuo Li, et al.
Pubblicazione: (2024)

PICC Maintenance Challenges Among Esophageal Cancer Patients: A Qualitative Study
di: Guo Huanfei, et al.
Pubblicazione: (2025)

The Black Hole of Immune Checkpoint Blocking Therapy for Gastric Cancer: Hyperprogressive Disease
di: Zhuan‐Fang Wang, et al.
Pubblicazione: (2025)

SARS‐CoV‐2 Infection Aggravates Physical and Mental Health in Cancer Patients Compared to Co‐Living Individuals
di: Jiayao Liu, et al.
Pubblicazione: (2025)

Significant Pathologic Response Following Neoadjuvant Therapy and Curative Resection in Patients With Rectal Cancer: Surgical and Oncological Outcomes From a Retrospective Cohort Study
di: Fatemeh Shahabi, et al.
Pubblicazione: (2024)

Improving Time to Bleeding Disorder Treatment in the Emergency Department
di: Lisa Littner, et al.
Pubblicazione: (2025)

Sensitivity of Platinum‐Based Chemotherapy and Efficacy of Arsenic Trioxide‐Based Non‐Platinum Chemotherapy Following the Progression of PARPi Maintenance Therapy: A Real‐World Study
di: Rui Gou, et al.
Pubblicazione: (2025)

Five‐year comparison of magnetic resonance imaging and endoscopy for nasopharyngeal carcinoma detection among high‐risk populations undergoing screening
di: Hang‐Ning Zhou, et al.
Pubblicazione: (2026)

Evaluation of Anticancer Therapy‐Related Tumor Flare Reaction: Insights From Food and Drug Administration's Adverse Event Reporting System Dataset
di: Wei Wang, et al.
Pubblicazione: (2026)

Cardiovascular Safety Landscape of ADT in Prostate Cancer Treatment Based on Real‐World Analysis
di: Wei Wang, et al.
Pubblicazione: (2025)

Quality and Reliability of Lung Cancer Treatment Short Videos on Chinese Social Media: A Cross‐Sectional Analysis for Cancer Education Improvement (January 1, 2020–October 30, 2025)
di: Zengrui Wang, et al.
Pubblicazione: (2026)

Association Between Maladaptive Cognitive Emotion Regulation and Fear of Cancer Recurrence in Breast Cancer Patients With a History of Suicide Attempts: A Cross‐Sectional Study
di: XinWei Zhang, et al.
Pubblicazione: (2026)

Anlotinib Plus Osimertinib in Osimertinib‐Resistant Nonsquamous Nonsmall Cell Lung Cancer With Gradual Progression: A Retrospective Study
di: Yu Hua, et al.
Pubblicazione: (2025)

Practice‐Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025
di: Zhenyu Zhou, et al.
Pubblicazione: (2026)

Reclassified the phenotypes of cancer types and construct a nomogram for predicting bone metastasis risk: A pan‐cancer analysis
di: Ming Li, et al.
Pubblicazione: (2024)

mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics
di: Bo Yang, et al.
Pubblicazione: (2025)

Sortilin‐1, Targeted by miR‐146a, Regulates the Behavior of Non‐Small Cell Lung Cancer
di: Xi Lin, et al.
Pubblicazione: (2025)

Tissue‐Resident Memory T Cells: Pioneering New Avenues in Cancer Immunotherapy
di: Yao Xiao, et al.
Pubblicazione: (2025)

CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
di: Can Chen, et al.
Pubblicazione: (2024)

Serinc2 Drives the Progression of Cervical Cancer Through Regulating Myc Pathway
di: Xiaoping Wang, et al.
Pubblicazione: (2024)

Immune Imbalance and Dynamic Characteristics of T Helper 17, Regulatory T, and Regulatory B Cells in Children With Persistent Immune Thrombocytopenia
di: Peiling Li, et al.
Pubblicazione: (2025)

Prognostic Significance, Radiological, and Metabolic Characteristics of Metastatic Lymph Nodes in Resectable Non‐Small Cell Lung Cancer Following Neoadjuvant Chemoimmunotherapy
di: Tianxiao Han, et al.
Pubblicazione: (2025)

Translational Inhibition of Slug by Pdcd4 Contributes to Invasion Inhibition in Colorectal Cancer Cells
di: Qing Wang, et al.
Pubblicazione: (2025)

A venetoclax‐cytarabine‐based induction regimen incorporating a translation inhibitor for adult patients with de novo acute myeloid leukemia
di: Xiao‐Hua Luo, et al.
Pubblicazione: (2026)

Prevalence and Correlates of Distress Detected by the Distress Thermometer and Problem List in Lung Cancer Patients: A Cross‐Sectional Study
di: Xiaomin Wei, et al.
Pubblicazione: (2025)

Development and Validation of an MRI‐Based Radiomics Nomogram to Predict the Prognosis of De Novo Oligometastatic Prostate Cancer Patients
di: Wen‐Qi Liu, et al.
Pubblicazione: (2024)

Polygenic Risk Score as a Predictor of Bone Fracture or Osteoporosis in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
di: Ying‐Qiang Liu, et al.
Pubblicazione: (2025)

The Role of RANBP3L in Pan‐Cancer With Its Significance in Hepatocellular Carcinoma
di: Beini Cen, et al.
Pubblicazione: (2025)

Stem Cell‐Based Cancer Therapies: A Commentary on Therapeutic Promise, Health Impacts and Translational Barriers
di: Zar Soe Thin, et al.
Pubblicazione: (2025)

ACT001 Suppresses the Malignant Progression of Small‐Cell Lung Cancer by Inhibiting Lactate Production and Promoting Anti‐Tumor Immunity
di: Xiao‐Jing Ding, et al.
Pubblicazione: (2025)